Latest News Archive

Please select Category, Year, and then Month to display items

ScholarGPS honours Prof Hendrik Swart as highly ranked scholar

04 June 2024 | Story Leonie Bolleurs | Photo Kaleidoscope Studios

ScholarGPS awarded Prof Hendrik Swart, Senior Professor in the Department of Physics at the University of the Free State (UFS), Highly Ranked Scholar status.

ScholarGPS celebrates Highly Ranked Scholars™ for their performance in various fields, disciplines, and specialties. Prof Swart’s prolific publication record, the high impact of his work, and the outstanding quality of his scholarly contributions have placed him among the top 0,05% of all scholars worldwide.

Prof Swart received Highly Ranked Scholar status (Lifetime) for ranking 16th in the discipline of Phosphor. Highly Ranked Scholars™ – Lifetime refers to distinguished authors, including those who are currently active, retired, or deceased. These scholars are recognised for their exceptional lifetime scholarly contributions, placing them in the top 0,05% of all scholars. Their achievements are evaluated across four categories: overall (across all fields), within their specific field of study, within their particular discipline, and across all specialties they are associated with.

Additionally, Prof Swart received Highly Ranked Scholar status (prior five years) for ranking first in Condensed Matter Physics, 42nd in Physics, 155th in Sensor, 207th in Physical Science and Mathematics, and 969th in all fields.

Scientific profile and credibility

ScholarGPS is a California-based company that applies artificial intelligence, data mining, machine learning, and other data science techniques to its massive database of more than 200 million publications and 3 billion citations to rank more than 30 million scholars and 55 000 institutions worldwide. They categorise more than 200 million scholarly publications into specific academic specialties. These specialties are further organised into 177 disciplines and 14 overarching fields. As a result of this extensive classification effort, scholars who are considered highly ranked within their respective fields can now be identified with greater precision. This identification is done not only within each academic specialty, but also across disciplines and fields, providing a comprehensive view of scholarly achievement and expertise. This system allows for the identification of top scholars within various areas of academic research in a way that was not possible before.

Prof Swart, who is an NRF B1-rated researcher, currently also holds the SARChI Research Chair: Solid-state Luminescent and Advanced Materials (2023-2027). On receiving this award from ScholarGPS, he says it is always a privilege to be recognised as one of the top scholars in your specific field, especially at this late stage of his career.

Professionally, Prof Swart says this award may boost his scientific profile and credibility in the academic community, potentially leading to more collaborations and partnerships.

In the field of condensed matter physics, the impact of his work is specifically noteworthy in the study of defects and impurities within semiconductors, along with their practical applications in optoelectronic devices. Moreover, his significant contributions extend to understanding optical and electronic properties at the nanoscale, bearing implications for the development of semiconductor technology, including light-emitting diodes (LEDs), photovoltaic cells, and quantum dots.

Primarily focused on mentorship

He believes his successes in physics and advances in understanding the universe are the result of a combination of variables, including innovative research, collaboration and networking, mentorship, effective communication, persistence, and resilience. “I am primarily focused on mentorship, which is critical to developing the next generation of physicists and creating a supportive environment for learning and discovery, as well as conducting groundbreaking research and making novel discoveries that are critical to pushing the boundaries of physics. I am always searching for opportunities to collaborate with other scholars, both inside and outside my discipline, which will result in constructive exchange of ideas, interdisciplinary discoveries, and collective problem solving.”

News Archive

#Women'sMonth: Save the children

2017-08-10

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach
When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.”

A future without rotavirus vaccination?
Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept